These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 17944973)

  • 21. Mutation of threonine 34 in mouse podoplanin-Fc reduces CLEC-2 binding and toxicity in vivo while retaining antilymphangiogenic activity.
    Bianchi R; Fischer E; Yuen D; Ernst E; Ochsenbein AM; Chen L; Otto VI; Detmar M
    J Biol Chem; 2014 Jul; 289(30):21016-27. PubMed ID: 24907275
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A pull-down and slot blot-based screening system for inhibitor compounds of the podoplanin-CLEC-2 interaction.
    Watanabe N; Kidokoro M; Suzuki Y; Tanaka M; Inoue S; Tsukamoto H; Hirayama N; Hsieh PW; Tseng CP; Nakagawa Y; Inokuchi S
    PLoS One; 2019; 14(9):e0222331. PubMed ID: 31553741
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Platelets and cancer-associated thrombosis: focusing on the platelet activation receptor CLEC-2 and podoplanin.
    Suzuki-Inoue K
    Hematology Am Soc Hematol Educ Program; 2019 Dec; 2019(1):175-181. PubMed ID: 31808911
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A platform of C-type lectin-like receptor CLEC-2 for binding O-glycosylated podoplanin and nonglycosylated rhodocytin.
    Nagae M; Morita-Matsumoto K; Kato M; Kaneko MK; Kato Y; Yamaguchi Y
    Structure; 2014 Dec; 22(12):1711-1721. PubMed ID: 25458834
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Renal cells activate the platelet receptor CLEC-2 through podoplanin.
    Christou CM; Pearce AC; Watson AA; Mistry AR; Pollitt AY; Fenton-May AE; Johnson LA; Jackson DG; Watson SP; O'Callaghan CA
    Biochem J; 2008 Apr; 411(1):133-40. PubMed ID: 18215137
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cancer-associated fibroblasts promote venous thrombosis through podoplanin/CLEC-2 interaction in podoplanin-negative lung cancer mouse model.
    Shirai T; Tsukiji N; Sasaki T; Oishi S; Yokomori R; Takano K; Suzuki-Inoue K
    J Thromb Haemost; 2023 Nov; 21(11):3153-3165. PubMed ID: 37473844
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The platelet aggregation-inducing factor aggrus/podoplanin promotes pulmonary metastasis.
    Kunita A; Kashima TG; Morishita Y; Fukayama M; Kato Y; Tsuruo T; Fujita N
    Am J Pathol; 2007 Apr; 170(4):1337-47. PubMed ID: 17392172
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Blocking podoplanin suppresses growth and pulmonary metastasis of human malignant melanoma.
    Xu M; Wang X; Pan Y; Zhao X; Yan B; Ruan C; Xia L; Zhao Y
    BMC Cancer; 2019 Jun; 19(1):599. PubMed ID: 31208371
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Platelet-activating factor podoplanin: from discovery to drug development.
    Takemoto A; Miyata K; Fujita N
    Cancer Metastasis Rev; 2017 Jun; 36(2):225-234. PubMed ID: 28674748
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Platelet adhesion to podoplanin under flow is mediated by the receptor CLEC-2 and stabilised by Src/Syk-dependent platelet signalling.
    Navarro-Núñez L; Pollitt AY; Lowe K; Latif A; Nash GB; Watson SP
    Thromb Haemost; 2015 May; 113(5):1109-20. PubMed ID: 25694214
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The chimeric antibody chLpMab-7 targeting human podoplanin suppresses pulmonary metastasis via ADCC and CDC rather than via its neutralizing activity.
    Kato Y; Kunita A; Abe S; Ogasawara S; Fujii Y; Oki H; Fukayama M; Nishioka Y; Kaneko MK
    Oncotarget; 2015 Nov; 6(34):36003-18. PubMed ID: 26416352
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression of Aggrus/podoplanin in bladder cancer and its role in pulmonary metastasis.
    Takagi S; Oh-hara T; Sato S; Gong B; Takami M; Fujita N
    Int J Cancer; 2014 Jun; 134(11):2605-14. PubMed ID: 24222607
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Podoplanin and CLEC-2 drive cerebrovascular patterning and integrity during development.
    Lowe KL; Finney BA; Deppermann C; Hägerling R; Gazit SL; Frampton J; Buckley C; Camerer E; Nieswandt B; Kiefer F; Watson SP
    Blood; 2015 Jun; 125(24):3769-77. PubMed ID: 25908104
    [TBL] [Abstract][Full Text] [Related]  

  • 34. C-type lectin-like receptor 2 promotes hematogenous tumor metastasis and prothrombotic state in tumor-bearing mice.
    Shirai T; Inoue O; Tamura S; Tsukiji N; Sasaki T; Endo H; Satoh K; Osada M; Sato-Uchida H; Fujii H; Ozaki Y; Suzuki-Inoue K
    J Thromb Haemost; 2017 Mar; 15(3):513-525. PubMed ID: 28028907
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevention of hematogenous metastasis by neutralizing mice and its chimeric anti-Aggrus/podoplanin antibodies.
    Nakazawa Y; Takagi S; Sato S; Oh-hara T; Koike S; Takami M; Arai H; Fujita N
    Cancer Sci; 2011 Nov; 102(11):2051-7. PubMed ID: 21824222
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Establishment of Mouse Monoclonal Antibody LpMab-13 Against Human Podoplanin.
    Ogasawara S; Kaneko MK; Honma R; Oki H; Fujii Y; Takagi M; Suzuki H; Kato Y
    Monoclon Antib Immunodiagn Immunother; 2016 Jun; 35(3):155-62. PubMed ID: 27328060
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Essential in vivo roles of the platelet activation receptor CLEC-2 in tumour metastasis, lymphangiogenesis and thrombus formation.
    Suzuki-Inoue K
    J Biochem; 2011 Aug; 150(2):127-32. PubMed ID: 21693546
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Novel knock-in mouse model for the evaluation of the therapeutic efficacy and toxicity of human podoplanin-targeting agents.
    Ukaji T; Takemoto A; Shibata H; Kakino M; Takagi S; Katayama R; Fujita N
    Cancer Sci; 2021 Jun; 112(6):2299-2313. PubMed ID: 33735501
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tetraspanin family member CD9 inhibits Aggrus/podoplanin-induced platelet aggregation and suppresses pulmonary metastasis.
    Nakazawa Y; Sato S; Naito M; Kato Y; Mishima K; Arai H; Tsuruo T; Fujita N
    Blood; 2008 Sep; 112(5):1730-9. PubMed ID: 18541721
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Platelets play an essential role in murine lung development through Clec-2/podoplanin interaction.
    Tsukiji N; Inoue O; Morimoto M; Tatsumi N; Nagatomo H; Ueta K; Shirai T; Sasaki T; Otake S; Tamura S; Tachibana T; Okabe M; Hirashima M; Ozaki Y; Suzuki-Inoue K
    Blood; 2018 Sep; 132(11):1167-1179. PubMed ID: 29853539
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.